RCUS Arcus Biosciences, Inc.
$17.65▼ -0.62%
Healthcare
Other
Volume 115.5K
Avg Volume (10D) 3.66M
Key Metrics & Fundamentals
Market Cap
$2.22B
P/E Ratio
–
Div Yield
0.00%
52W Range
17.43 - 31.74
% vs 50 MA
-31.40%
% vs 200 MA
-28.23%
RSI-14
25.7
MACD Histogram
-0.4800
Beta (1Y vs SPY)
1.47
Free Cash Flow
-$119.00M
Gross Rev
$41.00M
Gross Profit
$41.00M
EBITDA
-$85.00M
COGS
–
Operating Exp
$137.00M
Operating Income
-$96.00M
EBIT
-$96.00M
Pretax Income
-$91.00M
Net Income
-$91.00M
EPS (Diluted)
-0.72
Price & Volume History
Loading chart…
Recent News
Arcus Biosciences Announces New Employment Inducement Grants
Business Wire · Oct 26, 2026 4:35 PM ET
How Investors May Respond To Arcus Biosciences (RCUS) $250 Million Share Sale
Simply Wall St. · Oct 24, 2026 5:13 PM ET
Arcus Biosciences (RCUS) Stock Looks Stretched As Casdatifan Trial Data Impresses
Simply Wall St. · Oct 24, 2026 3:09 PM ET
Arcus Biosciences Prices $250 Million Common Stock Offering; Shares Down Pre-Bell
MT Newswires · Oct 22, 2026 4:15 AM ET
Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock
Business Wire · Oct 21, 2026 10:53 PM ET
Arcus Biosciences stock falls on public offering announcement
Investing.com · Oct 21, 2026 6:32 PM ET
Arcus Biosciences Announces Commencement of Public Offering of Common Stock
Business Wire · Oct 21, 2026 4:22 PM ET
William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage
Business Wire · Oct 21, 2026 12:30 PM ET
Arcus kidney cancer data impresses analysts; TriGemX inks a SPAC deal
BioPharma Dive · Oct 21, 2026 10:23 AM ET
Can Expanding Ivonescimab Development Unlock SMMT's Growth Potential?
Zacks · Oct 21, 2026 10:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See RCUS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.